Burjeel Medical City and New York-based Roswell Park launch clinical and academic collaboration

Burjeel Medical City and Roswell Park Cancer Institute Forge Partnership to Enhance Thoracic Cancer Care in the UAE

In a significant development for cancer treatment in the United Arab Emirates, Burjeel Medical City has announced a groundbreaking clinical and academic collaboration with the renowned Roswell Park Comprehensive Cancer Center based in New York. This partnership aims to bolster thoracic cancer care and research, positioning the UAE as a leader in innovative oncology practices.

The collaboration was officially unveiled during a ceremony at Burjeel Medical City, attended by prominent figures from both institutions, including leading oncologists, researchers, and healthcare executives. The partnership reflects a shared commitment to improving patient outcomes through advanced clinical practices, cutting-edge research, and educational initiatives.

Advancing Cancer Care Through Collaboration

Thoracic cancer, which primarily includes lung cancer and esophageal cancer, poses a significant health challenge globally, with the UAE experiencing a rising incidence of these diseases. The collaboration between Burjeel Medical City and Roswell Park aims to address this pressing issue by integrating world-class expertise and resources to enhance diagnostics, treatment protocols, and patient care strategies.

Dr. Maan Al Awadhi, the Executive Director of Burjeel Medical City, expressed enthusiasm about the partnership, stating, “This collaboration represents a pivotal step in our commitment to providing state-of-the-art cancer care in the UAE. By joining forces with Roswell Park, we are not only enhancing our clinical capabilities but also fostering a culture of academic excellence and research-driven practices.”

Key Initiatives and Objectives

The collaboration is designed to encompass several key initiatives aimed at elevating thoracic cancer care:

• Clinical Protocol Development: Experts from Roswell Park will work alongside Burjeel’s oncology team to develop and implement advanced clinical protocols tailored to the needs of the local population.
• Research and Innovation: Joint research initiatives will focus on thoracic cancer, exploring novel treatment options and improving existing therapies through clinical trials.
• Education and Training: The partnership will facilitate training programs and workshops for healthcare professionals, enhancing their skills in diagnosing and treating thoracic cancers.
• Patient Support Services: New patient support programs will be introduced, aimed at improving the overall care experience for individuals diagnosed with thoracic cancers.

A Global Approach to Local Challenges

Roswell Park, one of the oldest cancer research centers in the United States, brings a wealth of experience and expertise to the collaboration. The institute has a long-standing reputation for pioneering cancer research and developing innovative treatment modalities. By leveraging this expertise, Burjeel Medical City aims to provide patients in the UAE with access to the latest advancements in cancer care.

Dr. Candace Johnson, President and CEO of Roswell Park, emphasized the importance of this partnership, stating, “Our collaboration with Burjeel Medical City is an exciting opportunity to expand our impact on cancer care beyond the borders of the United States. Together, we can improve the lives of patients in the UAE and contribute to global cancer research.”

Looking Ahead

As the UAE continues to invest in its healthcare infrastructure, partnerships like the one between Burjeel Medical City and Roswell Park are vital to enhancing the quality of care available to patients. This collaboration not only promises to improve thoracic cancer outcomes but also sets a precedent for future international partnerships in the field of oncology.

With the shared goal of advancing cancer care through research, education, and innovative treatment, this collaboration marks a promising new chapter in the fight against thoracic cancer in the UAE.